Anti-tumour necrosis factor alpha monoclonal antibody therapy for recalcitrant cerebral vasculitis in a patient with Behçet's syndrome

Ann Rheum Dis. 2003 Mar;62(3):280-1. doi: 10.1136/ard.62.3.280.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antirheumatic Agents / therapeutic use*
  • Behcet Syndrome / complications*
  • Female
  • Humans
  • Infliximab
  • Magnetic Resonance Imaging
  • Middle Aged
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / immunology*
  • Vasculitis, Central Nervous System / drug therapy*

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab